How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Recursive self-improvement AI now has a co-evolving evaluator: a Cambridge and NVIDIA preprint introduces the Red Queen Gödel ...
Buffer overflow vulnerabilities have driven remote code execution for decades and keep appearing in critical network ...
Autonomous AI post-training reached frontier scale for the first time: NVIDIA researchers published a paper showing an AI ...
IBM says it can fit nearly 100 billion transistors on a chip - why the milestone matters ...
OpenAI and Broadcom unveiled Jalapeño, a custom AI inference chip designed in nine months. Early tests show 50% cost savings over standard GPUs, with deployment planned for late 2026.
The company, along with others, is pursuing a new paradigm for cramming more transistors on chips—building up.
The compiler infers, but does not take instructions. There is no syntax for explicit type declarations yet, and the new type ...